Artículos de revistas sobre el tema "Anti-TB Therapy"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Anti-TB Therapy".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Ye, L., L. Wu, J. Tang, R. Mao y Q. Cao. "P502 Different presentation of tuberculosis associated with anti-TNF therapy among patients with Inflammatory Bowel Disease in endemic area: observation from China". Journal of Crohn's and Colitis 16, Supplement_1 (1 de enero de 2022): i464. http://dx.doi.org/10.1093/ecco-jcc/jjab232.629.
Texto completoMandic, Dragana, Radmila Curcic, Gordana Radosavljevic, Nemanja Damjanov, Dusan Stefanovic, Igor Mitic y Aleksandar Dimic. "Recommendations for tuberculosis screening before and during treatment with tumour necrosis factor inhibitors". Srpski arhiv za celokupno lekarstvo 137, n.º 3-4 (2009): 211–16. http://dx.doi.org/10.2298/sarh0904211m.
Texto completoMazlun, Muhamad Harith, Siti Fatimah Sabran, Maryati Mohamed, Mohd Fadzelly Abu Bakar y Zunoliza Abdullah. "Phenolic Compounds as Promising Drug Candidates in Tuberculosis Therapy". Molecules 24, n.º 13 (4 de julio de 2019): 2449. http://dx.doi.org/10.3390/molecules24132449.
Texto completoIbrahim, Chandra Satria. "Anti-TB Drug for Tuberculosis Spondylitis". Neurologico Spinale Medico Chirurgico 1, n.º 2 (7 de agosto de 2018): 18. http://dx.doi.org/10.15562/nsmc.v1i2.96.
Texto completoNoguera-Julian, Antoni, Joan Calzada-Hernández, Folke Brinkmann, Robindra Basu Roy, Olga Bilogortseva, Michael Buettcher, Isabel Carvalho et al. "Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study". Clinical Infectious Diseases 71, n.º 10 (4 de diciembre de 2019): 2561–69. http://dx.doi.org/10.1093/cid/ciz1138.
Texto completoKumar, P., S. K. Vuyyuru, B. Kante, P. Sahu, S. Goyal, D. Madhu, S. Jain et al. "P531 Stringent screening strategy significantly reduces reactivation rate of Tuberculosis in Patients with Inflammatory Bowel Disease on anti-TNF therapy in a TB endemic region". Journal of Crohn's and Colitis 16, Supplement_1 (1 de enero de 2022): i484. http://dx.doi.org/10.1093/ecco-jcc/jjab232.658.
Texto completoPaz, M. E. Pinto, L. Bueno Lazo, D. Carrera Palao, D. F. Pinto Ruiz, M. R. Huaman y A. M. Quispe. "Efficacy and safety of oncoplastic surgery plus drug therapy for chronic tuberculous granulomatous mastitis". International Journal of Tuberculosis and Lung Disease 24, n.º 6 (1 de junio de 2020): 585–90. http://dx.doi.org/10.5588/ijtld.19.0478.
Texto completoSugiyama, Yuya, Nobuhiro Ueno, Shion Tachibana, Yu Kobayashi, Yuki Murakami, Takahiro Sasaki, Aki Sakatani et al. "The safety of vedolizumab in a patient with Crohn’s disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report". Medicine 102, n.º 28 (14 de julio de 2023): e34331. http://dx.doi.org/10.1097/md.0000000000034331.
Texto completoHidayat, Edi Yanuarto, Nasirun Zulqarnain y Muchlis Achsan Udji Sofro. "Perbandingan Gambaran Foto Toraks Pasien TB-HIV Dua dan Enam Bulan Pengobatan Anti-Tuberkulosis + Anti-Retroviral". Jurnal Radiologi Indonesia 1, n.º 2 (1 de septiembre de 2015): 91–98. http://dx.doi.org/10.33748/jradidn.v1i2.12.
Texto completoFrolova, K. S. y S. E. Borisov. "RISK OF DEVELOPING ACTIVE TB IN IBD PATIENTS TREATED WITH ATNI-TNF". Koloproktologia, n.º 1 (30 de marzo de 2018): 49–56. http://dx.doi.org/10.33878/2073-7556-2018-0-1-49-56.
Texto completoYoo, Jung-Wan, Kyung-Wook Jo, Bo-Hyung Kang, Mi Young Kim, Bin Yoo, Chang-Keun Lee, Yong-Gil Kim et al. "Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy". European Respiratory Journal 44, n.º 5 (7 de agosto de 2014): 1289–95. http://dx.doi.org/10.1183/09031936.00063514.
Texto completoMaarman, Gerald` J. "Could melatonin be an adjunct therapy for post-TB lung disease?" Melatonin Research 4, n.º 3 (30 de septiembre de 2021): 431–39. http://dx.doi.org/10.32794/mr112500103.
Texto completoTan, J., N. Hejazifar, E. Vantomme y K. Tsoi. "A175 RECURRENT GASTROINTESTINAL BLEED – A LATE MANIFESTATION OF COLONIC TUBERCULOSIS TREATED CONSERVATIVELY". Journal of the Canadian Association of Gastroenterology 3, Supplement_1 (febrero de 2020): 41–42. http://dx.doi.org/10.1093/jcag/gwz047.174.
Texto completoOshima, M., A. Fukui y Y. Takakura. "A CASE OF TUBERCULOUS TENOSYNOVITIS IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS". Hand Surgery 09, n.º 01 (julio de 2004): 109–13. http://dx.doi.org/10.1142/s0218810404002042.
Texto completoKim, Minji Jennifer, Nicholas Jones y Laura R. Steeples. "Miliary tuberculosis developing during adalimumab treatment for Behçet’s disease with uveitis". BMJ Case Reports 11, n.º 1 (diciembre de 2018): e226772. http://dx.doi.org/10.1136/bcr-2018-226772.
Texto completoHuang, Xiaojing, Xiao Zheng y Chenyang Shen. "Antiviral Therapy with Entecavir following Antituberculosis Therapy Alleviates Liver Injury and Restores Innate Immunity in Tuberculosis Patients Coinfected with Hepatitis B Virus". Evidence-Based Complementary and Alternative Medicine 2021 (2 de noviembre de 2021): 1–8. http://dx.doi.org/10.1155/2021/2884151.
Texto completoProsvetov, Yu V., A. Yu Gusarova, S. S. Barinov y A. V. Husarova. "CORRECTION OF SOME SIDE EFFECTS TO ANTI-TUBERCULOSIS THERAPY IN MODERN CONDITIONS". Modern medical technology, n.º 2(53) (10 de junio de 2022): 19–25. http://dx.doi.org/10.34287/mmt.2(53).2022.4.
Texto completoZeller, Michelle P., Jan H. Beumer, Susan M. Christner y Anargyros Xenocostas. "Pharmacokinetics of Dasatinib in a Patient with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Treatment with Anti-Tuberculosis Therapy". Blood 118, n.º 21 (18 de noviembre de 2011): 5006. http://dx.doi.org/10.1182/blood.v118.21.5006.5006.
Texto completoNasser, Abdullah Al Shekeili, Muhammad Tareq Khan Yaseer y Ismail Mousa Tia Khalid. "Use of Corticosteroid as an Adjunct with Antitubercular Therapy in the Management of Miliary Tuberculosis Associated with Organizing PneumoniaA Case Report". Journal of Clinical Cases & Reports 2, n.º 1 (31 de enero de 2019): 5–11. http://dx.doi.org/10.46619/joccr.2019.2-1029.
Texto completoSingh, Dhiraj Kumar, Sultan Tousif, Ashima Bhaskar, Annu Devi, Kriti Negi, Barnani Moitra, Anand Ranganathan, Ved Prakash Dwivedi y Gobardhan Das. "Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis". PLOS Pathogens 17, n.º 8 (20 de agosto de 2021): e1009805. http://dx.doi.org/10.1371/journal.ppat.1009805.
Texto completoMdivani, Nino, Haijing Li, Maka Akhalaia, Medea Gegia, Leila Goginashvili, Douglas S. Kernodle, George Khechinashvili y Yi-Wei Tang. "Monitoring Therapeutic Efficacy by Real-Time Detection of Mycobacterium tuberculosis mRNA in Sputum". Clinical Chemistry 55, n.º 9 (1 de septiembre de 2009): 1694–700. http://dx.doi.org/10.1373/clinchem.2009.124396.
Texto completoRibeiro-Rodrigues, Rodrigo, Tatiana Resende Co, John L. Johnson, Fabiola Ribeiro, Moises Palaci, Ricardo T. Sá, Ethel L. Maciel et al. "Sputum Cytokine Levels in Patients with Pulmonary Tuberculosis as Early Markers of Mycobacterial Clearance". Clinical and Vaccine Immunology 9, n.º 4 (julio de 2002): 818–23. http://dx.doi.org/10.1128/cdli.9.4.818-823.2002.
Texto completoTodoriko, L. D., О. V. Pidverbetska, І. О. Semianiv, І. V. Yeremenchuk y М. М. Kuzhko. "Applications of infusion therapy in the difficult form of tuberculosis". Infusion & Chemotherapy, n.º 3.1 (11 de octubre de 2020): 77. http://dx.doi.org/10.32902/2663-0338-2020-3.1-64.
Texto completoAlghamdi, Wael A., Sampson Antwi, Anthony Enimil, Hongmei Yang, Albert Dompreh, Lubbe Wiesner, Taimour Langaee, Charles A. Peloquin y Awewura Kwara. "Population pharmacokinetics of efavirenz in HIV and TB/HIV coinfected children: the significance of genotype-guided dosing". Journal of Antimicrobial Chemotherapy 74, n.º 9 (26 de junio de 2019): 2698–706. http://dx.doi.org/10.1093/jac/dkz238.
Texto completoSubhash, H. S., I. Ashwin, U. Mukundan, D. Danda, G. John, A. M. Cherian y K. Thomas. "Drug Resistant Tuberculosis in Diabetes Mellitus: A Retrospective Study from South India". Tropical Doctor 33, n.º 3 (julio de 2003): 154–56. http://dx.doi.org/10.1177/004947550303300311.
Texto completoP. R., Shreenivas y S. Nagaraja Prasad. "Study of price variation among the different brands of anti-tubercular drugs available in India". International Journal of Basic & Clinical Pharmacology 6, n.º 3 (24 de febrero de 2017): 660. http://dx.doi.org/10.18203/2319-2003.ijbcp20170832.
Texto completoA, Vijayalakshmi, Thanmayi G y Jayakumari S. "A PROSPECTIVE STUDY ON ABNORMAL LFT PATTERNS IN PATIENTS RECEIVING ANTITUBERCULOSIS THERAPY". Asian Journal of Pharmaceutical and Clinical Research 9, n.º 5 (1 de septiembre de 2016): 136. http://dx.doi.org/10.22159/ajpcr.2016.v9i5.12756.
Texto completoDas, Priya, Asesh Banerjee y Dr Prithviraj Karak. "Molecular Interplay between Vitamin D and Immunity can Aid Antitubercular Treatment Vitamin D in Immunomodulation of TB". Defence Life Science Journal 7, n.º 3 (13 de septiembre de 2022): 209–20. http://dx.doi.org/10.14429/dlsj.7.17566.
Texto completoDavarpanah, Mohammad Ali y Seyed Mohammad Hoseini. "Incidence of Active Tuberculosis Among Human Immunodeficiency Virus (HIV)-Positive Patients and Evaluation of Their Responses to Usual Anti-Tuberculosis Medications in Shiraz, South West of Iran". Galen Medical Journal 4, n.º 2 (21 de marzo de 2015): 115–20. http://dx.doi.org/10.31661/gmj.v4i2.260.
Texto completoRawal, Gautam, Sankalp Yadav y Sujana Rajamma. "Myocardial tuberculosis: A rare case report". Discussion of Clinical Cases 9, n.º 2 (6 de marzo de 2023): 13. http://dx.doi.org/10.5430/dcc.v9n2p13.
Texto completoSaid, Bibie, Edwin Nuwagira, Alphonce Liyoyo, Rinah Arinaitwe, Catherine Gitige, Rhina Mushagara, Peter Buzaare et al. "Early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trial". BMJ Open 12, n.º 6 (junio de 2022): e061953. http://dx.doi.org/10.1136/bmjopen-2022-061953.
Texto completoTao, Lina, Xiaoyu Qu, Yue Zhang, Yanqing Song y Si-xi Zhang. "Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials". Canadian Journal of Gastroenterology and Hepatology 2019 (10 de enero de 2019): 1–11. http://dx.doi.org/10.1155/2019/3192351.
Texto completoRaymond E Eworo, Augusta C Nsonwu-Anyanwu, Unyime A Fabian, Patience A Akpan y Peace E Udo. "Nutritional background of low-income pulmonary tuberculosis patients on anti-tuberculosis therapy at Infectious Disease Hospital, Calabar, Nigeria: A case-control study". Open Access Research Journal of Science and Technology 5, n.º 1 (30 de julio de 2022): 070–79. http://dx.doi.org/10.53022/oarjst.2022.5.1.0044.
Texto completoKhadka, Anjan. "BEDAQUILINE: A long but much fruitful wait since seventies". Medical Journal of Shree Birendra Hospital 13, n.º 1 (19 de julio de 2015): 40–42. http://dx.doi.org/10.3126/mjsbh.v13i1.13000.
Texto completoEsmael, Ahmed, Adane Mihret, Tamrat Abebe, Daniel Mussa, Sebsibe Neway, Joel Ernst, Jyothi Rengarajan, Liya Wassie y Rawleigh Howe. "Persistent expression of activation markers on Mycobacterium tuberculosis-specific CD4 T cells in smear negative TB patients". PLOS ONE 17, n.º 8 (30 de agosto de 2022): e0271234. http://dx.doi.org/10.1371/journal.pone.0271234.
Texto completoGarfein, R. S., L. Liu, J. Cuevas-Mota, K. Collins, D. G. Catanzaro, F. Muñoz, K. Moser et al. "Evaluation of recorded video-observed therapy for anti-tuberculosis treatment". International Journal of Tuberculosis and Lung Disease 24, n.º 5 (1 de mayo de 2020): 520–25. http://dx.doi.org/10.5588/ijtld.19.0456.
Texto completoAdeniji, Adetomiwa A., Kirsten E. Knoll y Du Toit Loots. "Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus". Applied Microbiology and Biotechnology 104, n.º 13 (5 de mayo de 2020): 5633–62. http://dx.doi.org/10.1007/s00253-020-10606-y.
Texto completoSutanto, Yusup Subagio, Magdalena Sutanto Sutanto y Agnes Sri Harti. "Anti-Tuberculosis Drugs against the Resistance Level of Mycobacterium tuberculosis isolates". Jurnal Kesehatan Masyarakat 17, n.º 1 (24 de julio de 2021): 14–23. http://dx.doi.org/10.15294/kemas.v17i1.24158.
Texto completoTang, Peijun, Xingnian Chen, Junchi Xu, Yunlong Hu, Zhijian Ye, Xiafang Wang, Yumei Xiao et al. "Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis". Journal of Immunology Research 2022 (17 de marzo de 2022): 1–10. http://dx.doi.org/10.1155/2022/2943113.
Texto completoShevchenko, Olha S., Liliia D. Todoriko, Olha O. Pohorelova, Ihor O. Semianiv, Irina A. Ovcharenko, Rostislav S. Shevchenko, Stanislav I. Shevchenko, Inga V. Yeremenchuk, Olena V. Pidverbetska y Yana I. Toderika. "FUNCTIONAL STATE OF THE LIVER IN PULMONARY TUBERCULOSIS IN THE DYNAMICS OF PATHOGENETIC TREATMENT WITH A COMPLEX OF AMINO ACIDS". Wiadomości Lekarskie 76, n.º 2 (2023): 352–59. http://dx.doi.org/10.36740/wlek202302116.
Texto completoAbdulaziz, S., S. Attar, W. Bajhammoh, E. A. Sindi, D. M. Ayish y E. Bakhashwain. "POS1153 EFFECTIVENESS OF SCREENING IN PATIENTS WITH RHEUMATIC DISEASE ON BIOLOGICAL THERAPY AND RISK OF ACTIVE TUBERCULOSIS". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 855.1–856. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1617.
Texto completoKale, Monali Raghunath, Mirza Shiraz Baig y Avinash Lamb. "A prospective observational pharmacovigilance study of adverse drug reaction monitoring in patients of tuberculosis receiving category I and II treatment regimens at tertiary care hospital". International Journal of Basic & Clinical Pharmacology 8, n.º 5 (23 de abril de 2019): 875. http://dx.doi.org/10.18203/2319-2003.ijbcp20191568.
Texto completoMuhammad, N., S. Mehboob y M. Abbas. "Pyrazinamide Induced Hyperuricemia in the Induction Phase of Anti-Tuberculosis Therapy". Pakistan Journal of Medical and Health Sciences 15, n.º 5 (30 de mayo de 2021): 1136–38. http://dx.doi.org/10.53350/pjmhs211551136.
Texto completoGoovaerts, Odin, Marguerite Massinga-Loembé, Pascale Ondoa, Ann Ceulemans, William Worodria, Harriet Mayanja-Kizza, Robert Colebunders y Luc Kestens. "Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS". PLOS ONE 15, n.º 12 (31 de diciembre de 2020): e0244800. http://dx.doi.org/10.1371/journal.pone.0244800.
Texto completoXi, Ying, Wei Zhang, Rui-Jun Qiao y Jun Tang. "Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis". PLOS ONE 17, n.º 6 (16 de junio de 2022): e0270003. http://dx.doi.org/10.1371/journal.pone.0270003.
Texto completoLancella, Laura, Luciana Abate, Laura Cursi, Giulia Chiopris, Laura Nicoletti, Nicola Principi, Alberto Villani y Susanna Esposito. "Abdominal Tuberculosis in Children: A Case Series of Five Patients". Microorganisms 11, n.º 3 (12 de marzo de 2023): 730. http://dx.doi.org/10.3390/microorganisms11030730.
Texto completoLozovskaya, Marina E., Yulia A. Yarovaya, Elena B. Vasilieva, Ludmila V. Klochkova, Elena A. Malysheva y Olga M. Noskova. "Combination of tuberculosis of the intra thoracic lymph nodes and acute lymphoblastic leukemia in a child". Pediatrician (St. Petersburg) 12, n.º 6 (18 de abril de 2022): 89–96. http://dx.doi.org/10.17816/ped12689-96.
Texto completoDutta, Noton K., Natalie Bruiners, Matthew D. Zimmerman, Shumin Tan, Véronique Dartois, Maria L. Gennaro y Petros C. Karakousis. "Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice". Journal of Infectious Diseases 221, n.º 7 (12 de octubre de 2019): 1079–87. http://dx.doi.org/10.1093/infdis/jiz517.
Texto completoKaushal, Deepak, Dhiraj K. Singh y Smriti Mehra. "Immune Responses in Lung Granulomas during Mtb/HIV Co-Infection: Implications for Pathogenesis and Therapy". Pathogens 12, n.º 9 (1 de septiembre de 2023): 1120. http://dx.doi.org/10.3390/pathogens12091120.
Texto completoNovikov, Vasiliy E., Natalia E. Usacheva y Tatyana V. Myakisheva. "Modern approaches to pharmacotherapy of tuberculosis infection in children". Research Results in Pharmacology 7, n.º 4 (3 de diciembre de 2021): 47–53. http://dx.doi.org/10.3897/rrpharmacology.7.66627.
Texto completo